PL Developments Brings Avéma Pharma Solutions under PLD Brand
PLD's Miami facility includes upgraded R&D and Analytical labs.
PL Developments (PLD) has brought its contract services division, Avéma Pharma Solutions, under the PLD brand as PLD Pharma Services. With this move, PLD aims to reduce confusion in the market by presenting a unified identity that reflects PLD’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers.
PL Developments (PLD) has brought its contract services division, Avéma Pharma Solutions, under the PLD brand as PLD Pharma Services. With this move, PLD aims to reduce confusion in the market by presenting a unified identity that reflects PLD’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers.
As a full service CDMO, Avéma had built a strong reputation for its full range of product development capabilities – providing integrated support from concept through development, pilot production, full scale manufacturing, and regulatory approvals. By bringing Avéma’s expertise under the PLD brand the company is creating a stronger, more unified presence in the CDMO market. This transition ensures that its clients experience a seamless, consistent partnership from a single trusted brand.
With more than 40 years of OTC drug development, PLD has developed an extensive library of base formulations and has experience working with a wide range of APIs in both solid and liquid dosage forms. This allows PLD Pharma Services to leverage that expertise and develop innovative drug delivery systems that are helping to increase patient compliance and o explore in In the contract manufacturing space, PLD is able to leverage their experience with solid and liquid dosage forms to introduce innovative drug delivery systems that will respond to evolving market demands and help increase patient compliance.
The rebranding comes at a time when PLD has invested in several infrastructure upgrades including:
· Establishing a new FDA and CGMP-compliant gummy manufacturing facility in New York to cater to the growing demand for gummies.
· Adding three full-turnkey bottling, labeling and packaging lines in our Lynwood facility to support the growth of OTC liquids
· Installing two new Korsch tablet presses, known for their precision and efficiency, in tablet production in Miami.
· Adding fluid bed coating capabilities and advanced granulation techniques to develop delayed release products.
· Expanding and enhancing our Analytical Development and R&D Labs in Miami, installing new equipment and adding headcount. The Analytical Development Lab is already up and running and our new R&D lab will go live in Q2.
Visit PLD Pharma Services at CPhI at Booth #816 to learn how we can help you develop and commercialize your next projects and take advantage of our experience and expertise or visit our website at www.pldpharma.com.
About PL Developments
Founded in 1988 and headquartered in Westbury, NY, PL Developments is a leading developer, manufacturer, packager, and distributor of consumer healthcare products, as well as liquid and solid dose OTC and Rx drugs. PLD operates eleven pharmaceutical manufacturing facilities across the United States, encompassing more than 2 million square feet of real estate and employing 1,600 people. Its contract manufacturing and development capabilities offer turnkey product development and manufacturing capabilities, with the ability to handle a full spectrum of drug outsourcing needs.
